DRX-065: Phase Ia started

DeuteRx began an open-label, U.S. Phase Ia trial to compare 22.5 mg DRX-065 vs. 45 mg Actos pioglitazone in up to 12 healthy adult volunteers. Pending data from the 2 cohorts, a third cohort of 6 vol...